Dublin, Aug. 10, 2017 -- The "Pharma App Benchmarking 2017" report has been added to Research and Markets' offering.
Since the first report about the app publishing activities of leading Pharma companies was published in 2014, companies have intensified their activities in the digital health market. This report analyses the current status of the app publishing activities of the twelve leading Pharma companies globally. It also analyses newly established channels that Pharma use to partner with 3rd party companies, including accelerators/incubators, investment funds and direct partnerships.
The research provides a detailed perspective on the current status of digital health activities, on a market and company level. It compares the digital health activities that Pharma companies concentrate on, and how successful they are. The report also highlights how app publishing strategies have changed over the last three years.
Key Topics Covered:
1. Scope of the report
2. Management summary
3. The four channels used by Pharma to drive digital innovation with mHealth apps
4. The app publishing activities of top Pharma companies
5. Top 12 Pharma company app portfolio comparison
6. Top 12 Pharma company app profiles and digital health innovation activities
7. How can Pharma further evolve their digital health strategies?
8. Appendix
Companies Mentioned
- Abbott/Abbvie
- AstraZeneca
- Bayer Healthcare
- Bristol-Myers Squibb
- GlaxoSmithKline
- Johnson&Johnson
- Merck
- Merck, Sharpe and Dohme (MSD)
- Novartis
- Pfizer
- Roche
- Sanofi
For more information about this report visit https://www.researchandmarkets.com/research/c28hjv/pharma_app
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Pharmaceuticals


Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Instagram Outage Disrupts Thousands of U.S. Users
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Washington Post Publisher Will Lewis Steps Down After Layoffs
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 



